The human embryo as property? Cryopreservation and the challenges for law

The development of the new reproductive technologies has presented significant challenges for policy makers and law reformers. This article focuses on the particular challenges posed by cryopreservation of embryos. These issues are analysed through discussion of relevant Australian statutory provisions and United States case law. The article concludes with a consideration of whether the property model provides an appropriate framework for reproductive material.

HLA-G expression during preimplantation human embryo development.

HLA-G is a nonclassical class I major histocompatibility complex molecule with a restricted pattern of expression that includes the placental extravillus cytotrophoblast cells in direct contact with maternal tissues. Circumstantial evidence suggests that HLA-G may play a role in protection of the semiallogeneic human fetus. We examined whether HLA-G is expressed during the critical period of preimplantation human development and whether expression of this molecule could be correlated with the cleavage rate of embryos. Using reverse transcription PCR on surplus human embryos and unfertilized oocytes from patients undergoing in vitro fertilization we detected HLA-G heavy chain mRNA in 40% of 148 of blastocysts tested. The presence of HLA-G mRNA was also detected in unfertilized oocytes and in early embryos, but not in control cumulus oophorus cells. beta 2-Microglobulin mRNA was also found in those embryos expressing HLA-G. In concordance with our mRNA data, a similar proportion of embryos stained positive for HLA-G utilizing a specific monoclonal antibody. Interestingly, expression of HLA-G mRNA was associated with an increased cleavage rate, as compared to embryos lacking HLA-G transcript. Thus, HLA-G could be a functional homologue of the mouse Qa-2 antigen, which has been implicated in differences in the rate of preimplantation embryo development. To our knowledge, the presence of HLA-G mRNA and protein in human preimplantation embryos and oocytes has not been reported previously. The correlation of HLA-G mRNA expression with cleavage rate suggests that this molecule may play an important role in human pre-embryo development.

NMR studies of preimplantation embryo metabolism in human assisted reproductive techniques: a new biomarker for assessment of embryo implantation potential

There has been growing interest in understanding energy metabolism in human embryos generated using assisted reproductive techniques (ART) for improving the overall success rate of the method. Using NMR spectroscopy as a noninvasive tool, we studied human embryo metabolism to identify specific biomarkers to assess the quality of embryos for their implantation potential. The study was based on estimation of pyruvate, lactate and alanine levels in the growth medium, ISM1, used in the culture of embryos. An NMR study involving 127 embryos from 48 couples revealed that embryos transferred on Day 3 (after 72 h in vitro culture) with successful implantation (pregnancy) exhibited significantly (p < 10(-5)) lower pyruvate/alanine ratios compared to those that failed to implant. Lactate levels in media were similar for all embryos. This implies that in addition to lactate production, successfully implanted embryos use pyruvate to produce alanine and other cellular functions. While pyruvate and alanine individually have been used as biomarkers, the present study highlights the potential of combining them to provide a single parameter that correlates strongly with implantation potential. Copyright (C) 2012 John Wiley & Sons, Ltd.

Phosphorylation of ATPase subunits of the 26S proteasome

Abstract The 26S proteasome complex plays a major role in the non-lysosomal degradation of intracellular proteins. Purified 26S proteasomes give a pattern of more than 40 spots on 2DPAGE gels. The positions of subunits have been identified by mass spectrometry of tryptic peptides and by immunoblotting with subunit-specific antipeptide antibodies. Two-dimensional polyacrylamide gel electrophoresis of proteasomes immunoprecipitated from [32P]phosphate-labelled human embryo lung L-132 cells revealed the presence of at least three major phosphorylated polypeptides among the regulatory subunits as well as the C8 and C9 components of the core 20S proteasome. Comparison with the positions of the regulatory polypeptides revealed a minor phosphorylated form to be S7 (MSS1). Antibodies against S4, S6 (TBP7) and S12 (MOV34) all cross-reacted at the position of major phosphorylated polypeptides suggesting that several of the ATPase subunits may be phosphorylated. The phosphorylation of S4 was confirmed by double immunoprecipitation experiments in which 26S oteasomes were immunoprecipitated as above and dissociated and Antibodies against the non-ATPase subunit S10, which has been suggested by others to be phosphorylated, did not coincide with the position of a phosphorylated polypeptide. Some differences were observed in the 2D-PAGE pattern of proteasomes immunoprecipitated from cultured cells compared to purified rat liver 26S proteasomes suggesting possible differences in subunit compositions of 26S proteasomes.

Patents, Ethics and Stem Cell Research : The Case of hESC Innovation in Australia, Europe and the United States

Embryonic stem cells offer potentially a ground-breaking insight into health and diseases and are said to offer hope in discovering cures for many ailments unimaginable few years ago. Human embryonic stem cells are undifferentiated, immature cells that possess an amazing ability to develop into almost any body cell such as heart muscle, bone, nerve and blood cells and possibly even organs in due course. This remarkable feature, enabling embryonic stem cells to proliferate indefinitely in vitro (in a test tube), has branded them as a so-called miracle cure . Their potential use in clinical applications provides hope to many sufferers of debilitating and fatal medical conditions. However, the emergence of stem cell research has resulted in intense debates about its promises and dangers. On the one hand, advocates hail its potential, ranging from alleviating and even curing fatal and debilitating diseases such as Parkinson s, diabetes, heart ailments and so forth. On the other hand, opponents decry its dangers, drawing attention to the inherent risks of human embryo destruction, cloning for research purposes and reproductive cloning eventually. Lately, however, the policy battles surrounding human embryonic stem cell innovation have shifted from being a controversial research to scuffles within intellectual property rights. In fact, the ability to obtain patents represents a pivotal factor in the economic success or failure of this new biotechnology. Although, stem cell patents tend to more or less satisfy the standard patentability requirements, they also raise serious ethical and moral questions about the meaning of the exclusions on ethical or moral grounds as found in European and to an extent American and Australian patent laws. At present there is a sort of a calamity over human embryonic stem cell patents in Europe and to an extent in Australia and the United States. This in turn has created a sense of urgency to engage all relevant parties in the discourse on how best to approach patenting of this new form of scientific innovation. In essence, this should become a highly favoured patenting priority. To the contrary, stem cell innovation and its reliance on patent protection risk turmoil, uncertainty, confusion and even a halt on not only stem cell research but also further emerging biotechnology research and development. The patent system is premised upon the fundamental principle of balance which ought to ensure that the temporary monopoly awarded to the inventor equals that of the social benefit provided by the disclosure of the invention. Ensuring and maintaining this balance within the patent system when patenting human embryonic stem cells is of crucial contemporary relevance. Yet, the patenting of human embryonic stem cells raises some fundamental moral, social and legal questions. Overall, the present approach of patenting human embryonic stem cell related inventions is unsatisfactory and ineffective. This draws attention to a specific question which provides for a conceptual framework for this work. That question is the following: how can the investigated patent offices successfully deal with patentability of human embryonic stem cells? This in turn points at the thorny issue of application of the morality clause in this field. In particular, the interpretation of the exclusions on ethical or moral grounds as found in Australian, American and European legislative and judicial precedents. The Thesis seeks to compare laws and legal practices surrounding patentability of human embryonic stem cells in Australia and the United States with that of Europe. By using Europe as the primary case study for lessons and guidance, the central goal of the Thesis then becomes the determination of the type of solutions available to Europe with prospects to apply such to Australia and the United States. The Dissertation purports to define the ethical implications that arise with patenting human embryonic stem cells and intends to offer resolutions to the key ethical dilemmas surrounding patentability of human embryonic stem cells and other morally controversial biotechnology inventions. In particular, the Thesis goal is to propose a functional framework that may be used as a benchmark for an informed discussion on the solution to resolving ethical and legal tensions that come with patentability of human embryonic stem cells in Australian, American and European patent worlds. Key research questions that arise from these objectives and which continuously thread throughout the monograph are: 1. How do common law countries such as Australia and the United States approach and deal with patentability of human embryonic stem cells in their jurisdictions? These practices are then compared to the situation in Europe as represented by the United Kingdom (first two chapters), the Court of Justice of the European Union and the European Patent Office decisions (Chapter 3 onwards) in order to obtain a full picture of the present patenting procedures on the European soil. 2. How are ethical and moral considerations taken into account at patent offices investigated when assessing patentability of human embryonic stem cell related inventions? In order to assess this part, the Thesis evaluates how ethical issues that arise with patent applications are dealt with by: a) Legislative history of the modern patent system from its inception in 15th Century England to present day patent laws. b) Australian, American and European patent offices presently and in the past, including other relevant legal precedents on the subject matter. c) Normative ethical theories. d) The notion of human dignity used as the lowest common denominator for the interpretation of the European morality clause. 3. Given the existence of the morality clause in form of Article 6(1) of the Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions which corresponds to Article 53(a) European Patent Convention, a special emphasis is put on Europe as a guiding principle for Australia and the United States. Any room for improvement of the European morality clause and Europe s current manner of evaluating ethical tensions surrounding human embryonic stem cell inventions is examined. 4. A summary of options (as represented by Australia, the United States and Europe) available as a basis for the optimal examination procedure of human embryonic stem cell inventions is depicted, whereas the best of such alternatives is deduced in order to create a benchmark framework. This framework is then utilised on and promoted as a tool to assist Europe (as represented by the European Patent Office) in examining human embryonic stem cell patent applications. This method suggests a possibility of implementing an institution solution. 5. Ultimately, a question of whether such reformed European patent system can be used as a founding stone for a potential patent reform in Australia and the United States when examining human embryonic stem cells or other morally controversial inventions is surveyed. The author wishes to emphasise that the guiding thought while carrying out this work is to convey the significance of identifying, analysing and clarifying the ethical tensions surrounding patenting human embryonic stem cells and ultimately present a solution that adequately assesses patentability of human embryonic stem cell inventions and related biotechnologies. In answering the key questions above, the Thesis strives to contribute to the broader stem cell debate about how and to which extent ethical and social positions should be integrated into the patenting procedure in pluralistic and morally divided democracies of Europe and subsequently Australia and the United States.

El estatuto de la persona humana como centro del actual debate justificatorio de los derechos fundamentales y sus consecuencias

Resumen: El presente artículo aborda el tema del estatuto de la persona humana desde distintas concepciones: 1) la concepción política del constructivismo contractualista de Rawls; 2) la concepción relacional de la hermenéutica de Kauffmann; 3) la concepción ontológica del iusnaturalismo clásico de Hervada. Una vez analizadas las distintas concepciones aborda cómo se aplica al caso del embrión humano y cuáles son las consecuencias éticas y jurídicas de cada una de estas posiciones.

Humildad, respeto y servicio ante la dignidad personal del embrión humano

Resumen: Ciertamente, ningún dato biológico es por sí mismo suficiente para describir el milagro de la vida. Sin embargo, cuando la ciencia es entendida como un servicio a la humanidad, los científicos son capaces de brindarnos los conocimientos necesarios y suficientes para percibir una presencia personal desde el primer instante de la vida de cada embrión humano.

Sobre el embrión humano y la cuestión de la personeidad : un argumento de Luigi Ferrajoli y su discusión

Resumen: El texto analiza las afirmaciones defendidas sobre el estatuto entitativo del embrión y de la solución ética a la cuestión de la legitimidad del aborto provocado, en un trabajo del jurista y pensador italiano, Luigi Ferrajoli, defensor de lo que puede denominarse el bioderecho “liberal”, con una posición decisivamente tomada en favor de la eticidad del aborto. Se advierte que cada uno de sus argumentos parte de una premisa: considerar las afirmaciones de la Iglesia Católica como inexorablemente erróneas, especialmente en lo atinente a la relación entre moral y derecho. La consecuencia más grave de este tipo de argumentación es la deriva anti-humanista del pensamiento contemporáneo con la consiguiente pérdida de toda racionalidad lógica.

O status ontológico e moral do embrião humano

A presente dissertação é fruto de uma investigação filosófica, inserida na linha de pesquisa de Ética. Esse trabalho aprofunda uma discussão polêmica no contexto da Bioética, a saber: a manipulação de células embrionárias. Contudo, o autor não envereda seus esforços nas conse-quências éticas advindas das novas tecnologias produzidas pela Engenharia Genética, mas adentra na causa do problema, isto é, pretende antes saber se o embrião humano é ser vivo, ser humano e, principalmente, pessoa. Assim, o autor tem como objetivo principal investigar o status ontológico e moral do embrião humano. Nesse contexto, investiga o conceito de identidade pessoal, examinando-o - brevemente - à luz de duas teorias da Filosofia da Mente: internalista, que defende a construção do eu por bases internas; e a externalista, que advoga a construção do eu por bases externas. Elenca e analisa os atributos essenciais que concebe uma pessoa. Também pesquisa o conceito de dignidade humana e sua vinculação ao conceito de pessoa, tendo como base a filosofia moral de Immanuel Kant, através de sua obra Fundamentação da Metafísica dos Costumes. Além desta e da bibliografia utilizada sobre o tema, a fonte principal dessa discussão é a obra Ética Prática, do filósofo Peter Singer. Vale destacar que existem três posições dominantes dentro dessa temática: a) Teoria Concepcionalista, a qual argumenta que o embrião é pessoa desde a concepção e, por isso, desautoriza qualquer manipulação; b) Teoria Genético-Desenvolvimentista, a qual defende a pessoalidade do embrião a partir de diferentes etapas do seu desenvolvimento biológico e, desse modo, defende as pesquisas biomédicas; c) Teoria da Potencialidade da Pessoa, a qual advoga que o embrião ainda não tem a pessoalidade, no entanto, é um potencial ser humano e pessoa, e, por essa razão, sua integridade deve ser preservada. Ao final, o autor enumera as principais implicações éticas, psicológicas, sociais e jurídicas, uma vez determinados os estatutos ontológico e moral do embrião humano.

Free radical scavenging and antioxidant enzymes activation of polysaccharide extract from Nostoc sphaeroides

Nostoc sphaeroides Kuetzing has been used as a traditional medicine in China to treat a variety of ailments. This research identified the antioxidant activities of polysaccharide extract from Nostoc sphaeroides. The extract, which contains 46.2% carbohydrates, exhibited an effective scavenging capability on superoxide radical, hydroxyl radicals in non site-specific as well as site-specific assays, and also performed lipid peroxidation inhibition in a dose-dependent manner. Polysaccharide extract had no 1,1-diphenyl-2-picrylhydrazyl radical scavenging potential at all test concentrations. Activities of superoxide dismutase, catalase, and glutathione peroxidase in human embryo kidney 293 cells were increased effectively when Nostoc sphaeroides extract was applied. These results suggested that the use of N. sphaeroides in treating ailments may be based on the antioxidant capacities of polysaccharide composition.

Desarrollo Embrionario & Fetal

Written in Spanish, this document explains embryonic and fetal development.

Sonic hedgehog (SHH) mutation in patients within the spectrum of holoprosencephaly

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Avaliação de polimorfismos de genes metabolizadores de xenobióticos em pacientes com fissura labiopalatina atendidos no Estado do Pará

Fissura lábio palatina ou orofaciais é um dos mais frequentes defeitos congênitos existentes e vários estudos relacionam essa malformação a causas multifatoriais. Entre as diversas causas ambientais estão os hábitos etílicos e tabagistas maternos, assim como o uso de agrotóxico. A resposta do embrião humano a agentes teratogênicos é bem conhecida. Porém, sabe-se que organismos diferentes metabolizam de maneira distinta um mesmo componente químico, isto se deve a características genéticas intrínsecas relacionadas a diferentes funcionamentos enzimáticos. Tais diferenças podem ser investigadas a partir da análise de polimorfismos em genes relacionados ao metabolismo destes xenobióticos, que podem assim estar relacionados à etiogênese de fissuras lábio palatinas. O Objetivo do nosso estudo foi analisar polimorfismos em sete genes, PON1 (rs662), PON1 (rs854560), MTHFD1, CYP2E1, EPHX1, ABCB1, AHR, onde uma análise correlativa com fatores ambientais, como exposição a agrotóxicos foi realizada, a fim de avaliar se existe ou não influência das diferentes variantes polimórficas e tais interações ambientais na etiogênese das fissuras lábio palatinas. O número total de amostras analisadas foi de 166 indivíduos, sendo 83 pacientes acometidos por fissura, com idade média de 7 anos (DP 5 anos) e 83 mães dos mesmos. Em nossas amostras, o gênero masculino foi 64% do total de acometidos.; uma ficha para a coleta de dados epidemiológicos foi desenvolvida para o estudo; o material biológico coletado para análise foi sangue. A análise estatística foi realizada com os softwares bioEstat 5.3, SPSS 12.0 e PLINK 1.07. Nosso resultado consiste de quatro análises diferentes, para cada polimorfismo. Inicialmente, observamos as diferenças entre as frequências genotípicas encontradas nos acometidos e nas mães destes e aquelas das populações de indivíduos hígidos. Isto visando encontrar diferenças entre estes genótipos que possam justificar a gênese das FLP, frente à exposição das mães, e intrauterinamente, dos filhos ao agrotóxico. Num segundo momento, verificamos se houveram diferenças entre os genótipos maternos e dos acometidos, que pudessem representar diferenças significativas entre estes dois grupos de indivíduos (pois as mães, independentemente da exposição ao agrotóxico, poderiam ter FLP, caso o genótipo fosse de elevada importância) e que possam ter relação com a FLP. Em uma terceira análise, observamos se os genótipos encontrados nos indivíduos que apresentam FLP, estão relacionados à exposição relatada aos agrotóxicos, como fator etiológico destas más formações. Em ultima análise, visamos, por análise de regressão, verificar se a característica genotípica desses alvos de estudo, possa ter influenciado no fenótipo do tipo de fissura, seja somente labial, seja palatal ou labiopalatal. A distribuição dos tipos de fissuras entre os acometidos foi de 12% para fissuras somente labiais, 19% para fissuras somente palatais e 69% das fissuras em nosso grupo amostral atingiam o lábio e o palato.